{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:33:11Z","timestamp":1767969191288,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008056.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000}}],"reference-count":66,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008056.pub3","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T04:02:53Z","timestamp":1452830573000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Linezolid versus vancomycin for skin and soft tissue infections"],"prefix":"10.1002","volume":"2016","author":[{"given":"Jirong","family":"Yue","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi Rong","family":"Dong","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Chen","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Dermatology & Venereology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taixiang","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan J","family":"Liu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD008056.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjsurg.2009.08.045","article-title":"Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus","volume":"199","author":"Itani","year":"2010","journal-title":"American Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD008056.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/500139","article-title":"Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer","volume":"42","author":"Jaksic","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD008056.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jac\/dkm369","article-title":"Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan","volume":"60","author":"Kohno","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0004|cit4","first-page":"10","article-title":"A randomized, double-blinded, controlled, multicenter clinical trial of linezolid versus vancomycin in the treatment of gram positive bacterial infection","volume":"9","author":"Lin","year":"2009","journal-title":"Chinese Journal of Infection and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD008056.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijantimicag.2008.04.004","article-title":"Linezolid for the treatment of infections caused by Gram-positive pathogens in China","volume":"32","author":"Lin","year":"2008","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"4","key":"10.1002\/14651858.CD008056.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.amjsurg.2005.01.011","article-title":"Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus","volume":"189","author":"Sharpe","year":"2005","journal-title":"American Journal of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/109629603764655290","article-title":"Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial","volume":"4","author":"Li","year":"2003","journal-title":"Surgical Infections"},{"issue":"3","key":"10.1002\/14651858.CD008056.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1592\/phco.21.3.263.34198","article-title":"Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial","volume":"21","author":"Li","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1002\/14651858.CD008056.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD008056.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijantimicag.2005.09.003","article-title":"Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA)","volume":"26","author":"Itani","year":"2005","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"10.1002\/14651858.CD008056.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0149-2918(07)80085-3","article-title":"A comparison of costs and hospital length of stay associated with intravenous\/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients","volume":"29","author":"McCollum","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD008056.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1345\/aph.1G728","article-title":"Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections","volume":"40","author":"McKinnon","year":"2006","journal-title":"Annals of pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD008056.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD008056.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amjsurg.2004.08.045","article-title":"Linezolid eradicates MRSA better than vancomycin from surgical-site infections","volume":"188","author":"Weigelt","year":"2004","journal-title":"American Journal of Surgery"},{"issue":"2","key":"10.1002\/14651858.CD008056.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/595686","article-title":"Complicated skin and skin-structure infections and catheter-related bloodstream infections: Noninferiority of linezolid in a phase 3 study","volume":"48","author":"Wilcox","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"9 suppl","key":"10.1002\/14651858.CD008056.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/01.inf.0000086955.93702.c7","article-title":"Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates","volume":"22","author":"Deville","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"9 Suppl","key":"10.1002\/14651858.CD008056.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1097\/01.inf.0000087020.75886.93","article-title":"Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children","volume":"22","author":"Kaplan","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"9 SUPPL","key":"10.1002\/14651858.CD008056.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/01.inf.0000088671.35064.7c","article-title":"Linezolid for the treatment of complicated skin and skin structure infections in children","volume":"22","author":"Yogev","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0019|cit19","doi-asserted-by":"crossref","unstructured":"Bal AM Garau J Gould IM Liao CH Mazzei T Nimmo GR Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era? Journal of global antimicrobial resistance 2013 23 30","DOI":"10.1016\/j.jgar.2013.01.002"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Bhavnani SM Hammel JP Wart SA Rubino CM Reynolds DK Forrest A Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections Antimicrobial agents and chemotherapy 2015 372 80","DOI":"10.1128\/AAC.02531-14"},{"issue":"3","key":"10.1002\/14651858.CD008056.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1742-1241.2008.01958.x","article-title":"Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model","volume":"63","author":"Bounthavong","year":"2009","journal-title":"International Journal of Clinical Practice"},{"issue":"7","key":"10.1002\/14651858.CD008056.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10096-002-0753-x","article-title":"Efficacy and safety of linezolid in the treatment of skin and soft tissue infections","volume":"21","author":"Hau","year":"2002","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Janis JE Hatef DA Reece EM Wong C Does empiric antibiotic therapy change hand infection outcomes? Cost analysis of a randomized prospective trial in a county hospital Plastic and reconstructive surgery 2014","DOI":"10.1097\/PRS.0000000000000018"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0024|cit24","first-page":"26","article-title":"Commentary on Linezolid eradicates MRSA better than vancomycin from surgical-site infections","volume":"19","author":"Joseph","year":"2007","journal-title":"Foot and Ankle Quarterly--The Seminar Journal"},{"issue":"5","key":"10.1002\/14651858.CD008056.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/AAC.50.5.1910-1911.2006","article-title":"Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus? comment","volume":"50","author":"Kalil","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD008056.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.ijid.2010.10.003","article-title":"The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials","volume":"15","author":"Lipsky","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0027|cit27","first-page":"23","article-title":"Health economics. The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective","volume":"20","author":"McKinnon","year":"2007","journal-title":"Managed Care Interface"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1185\/030079906X162700","article-title":"Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections","volume":"23","author":"Patanwala","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Puzniak LA Morrow LE Huang DB Barreto J Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus Clinical therapeutics 2013 1557 70","DOI":"10.1016\/j.clinthera.2013.08.001"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Puzniak LA Capitano B Biswas P Lodise TP Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: A pooled data analysis Diagnostic microbiology and infectious disease 2014 295 301","DOI":"10.1016\/j.diagmicrobio.2013.11.001"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10198-008-0104-7","article-title":"Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany","volume":"10","author":"Schurmann","year":"2009","journal-title":"European Journal of Health Economics"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijantimicag.2009.09.013","article-title":"Linezolid versus vancomycin for the treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials","volume":"35","author":"Beibei","year":"2010","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"2","key":"10.1002\/14651858.CD008056.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1185\/03007990903454912","article-title":"Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): A meta-analysis","volume":"26","author":"Bounthavong","year":"2010","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD008056.pub3-BIB0034|cit34","first-page":"1161","article-title":"Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results","volume":"39","author":"Bouza","year":"2004","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0035|cit35","unstructured":"Deeks JJ Higgins JPT Altman DG on behalf of theCochrane Statistical Methods Group and the CochraneBias Methods Group (Editors) Chapter 9: Analysing data and undertaking meta-analyses In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD008056.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jama.1990.03440100097014","article-title":"The existence of publication bias and risk factors for its occurrence","volume":"263","author":"Dickersin","year":"1990","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD008056.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1445-2197.2009.05018.x","article-title":"Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis)","volume":"79","author":"Dodds","year":"2009","journal-title":"ANZ Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD008056.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/096228020101000502","article-title":"Statistical methods for the meta analysis of cluster randomization trials","volume":"10","author":"Donner","year":"2001","journal-title":"Statistical Methods in Medical Research"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008056.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2008.01922.x","article-title":"Treatment challenges in the management of complicated skin and soft-tissue infections","volume":"14","author":"Eisenstein","year":"2008","journal-title":"Clinical Microbiology and Infection"},{"issue":"5","key":"10.1002\/14651858.CD008056.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1086\/367653","article-title":"Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection","volume":"36","author":"Engemann","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008056.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkg466","article-title":"Managing skin and soft tissue infections: expert panel recommendations on key decision points","volume":"52","author":"Eron","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-3099(07)70312-2","article-title":"Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials","volume":"8","author":"Falagas","year":"2008","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0043|cit43","unstructured":"FDA Uncomplicated and complicated skin and skin structure infections--developing antimicrobial drugs for treatment. Guidance for Industry: Center for Drug Evaluation and Research (CDER) http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm071185.pdf 1998"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008056.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"ii5","DOI":"10.1093\/jac\/dki004","article-title":"Safety and efficacy of glycopeptide antibiotics","volume":"55","author":"Finch","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2006.12.009","article-title":"Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004)","volume":"58","author":"Fritsche","year":"2007","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD008056.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0149-2918(01)80043-6","article-title":"Linezolid: an oxazolidinone antimicrobial agent","volume":"23","author":"Fung","year":"2001","journal-title":"Clinical Therapeutics"},{"issue":"14","key":"10.1002\/14651858.CD008056.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2165\/00003495-200363140-00003","article-title":"A practical guide to the treatment of complicated skin and soft tissue infections","volume":"63","author":"Fung","year":"2003","journal-title":"Drugs"},{"issue":"7414","key":"10.1002\/14651858.CD008056.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0049|cit49","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors) In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0050|cit50","unstructured":"Higgins JPT Green S (editors) Chapter 16: Special topics in statistics In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD008056.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.diagmicrobio.2009.10.001","article-title":"Zyvox(R) Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008","volume":"65","author":"Jones","year":"2009","journal-title":"Diagnostic microbiology and infectious disease"},{"issue":"3","key":"10.1002\/14651858.CD008056.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00134-003-2088-1","article-title":"Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin","volume":"30","author":"Kollef","year":"2004","journal-title":"Intensive Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008056.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0054|cit54","unstructured":"Lefebvre C Manheimer E Glanville J on behalf of the Cochrane Information Retrieval Methods Group Chapter 6: Searching for studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD008056.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD008056.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-130-2-199901190-00012","article-title":"A novel antimicrobial agent joins the battle against resistant bacteria","volume":"130","author":"Moellering","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008056.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2006.05.009","article-title":"Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)","volume":"57","author":"Moet","year":"2007","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"7","key":"10.1002\/14651858.CD008056.pub3-BIB0058|cit58","first-page":"376\u201382","article-title":"Trends in antimicrobial utilization at a tertiary teaching hospital during a15-year period (1978\u20131992)","volume":"14","author":"Pallares","year":"1993","journal-title":"\u00a0Infection Control and Hospital Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD008056.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD008056.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dki355","article-title":"Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies","volume":"56","author":"Shorr","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD008056.pub3-BIB0061|cit61","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Search filters http:\/\/www.sign.ac.uk\/methodology\/filters.html#random"},{"issue":"2","key":"10.1002\/14651858.CD008056.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/cc1871","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam","year":"2003","journal-title":"Critical Care"},{"issue":"10","key":"10.1002\/14651858.CD008056.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"9277","key":"10.1002\/14651858.CD008056.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"issue":"36","key":"10.1002\/14651858.CD008056.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"13339","DOI":"10.1073\/pnas.0804276105","article-title":"The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning","volume":"105","author":"Wilson","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"10.1002\/14651858.CD008056.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0012-3692(15)33412-7","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008056.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T06:32:25Z","timestamp":1740983545000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008056.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Wounds Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008056.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}